FDA Adverse Event
Death
Summary report: N
SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM
MDR report key: 6088315
·
Received November 9, 2016
Report
- Report Number
- 2134265-2016-10087
- Event Type
- Death
- Date Received
- November 9, 2016
- Date of Event
- September 30, 2016
- Report Date
- October 12, 2016
- Manufacturer
- BOSTON SCIENTIFIC - GALWAY
- Product Code
- NIQ
- PMA / PMN Number
- P150003
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MN, US
- Reporter Occupation
- PATIENT FAMILY MEMBER OR FRIEND
Narratives
Additional Manufacturer Narrative · 1
DEVICE IS A COMBINATION PRODUCT. (B)((4). DEVICE EVALUATED BY MFR: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION. THE MANUFACTURING BATCH RECORD REVIEW CONFIRMED THAT THE DEVICE MET ALL MATERIAL, ASSEMBLY AND PERFORMANCE SPECIFICATIONS. THE CAUSE OF THE REPORTED DIFFICULTIES COULD NOT BE DETERMINED. (B)((4).
Description of Event or Problem · 1
SAME CASE AS MDR ID: 2134265-2016-10085, 2134265-2016-10086. IT WAS REPORTED THAT POST A STENTING TREATMENT PROCEDURE THE PATIENT DIED. THE PATIENT HAD THREE SYNERGY STENTS IMPLANTED AND WAS DISCHARGED. ON THE WAY HOME FOLLOWING HOSPITAL DISCHARGE, THE PATIENT EXPERIENCED ANOTHER "HEART ATTACK" AND DIED. THE PHYSICIAN MENTIONED TO THE PATIENT'S FAMILY THAT ONE OF THE SYNERGY STENTS "COLLAPSED."
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 741308 | SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM | BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM | NIQ | BOSTON SCIENTIFIC - GALWAY | H7493926028250 | 0018611889 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 45 YR | Death |